These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


360 related items for PubMed ID: 27685837

  • 1. CD163 levels, pro- and anti-inflammatory cytokine secretion of monocytes in children with pulmonary tuberculosis.
    Aktas Cetin E, Pur Ozyigit L, Gelmez YM, Cakir E, Gedik AH, Deniz G.
    Pediatr Pulmonol; 2017 May; 52(5):675-683. PubMed ID: 27685837
    [Abstract] [Full Text] [Related]

  • 2. Differential expression and predictive value of monocyte scavenger receptor CD163 in populations with different tuberculosis infection statuses.
    Liu Q, Ou Q, Chen H, Gao Y, Liu Y, Xu Y, Ruan Q, Zhang W, Shao L.
    BMC Infect Dis; 2019 Nov 28; 19(1):1006. PubMed ID: 31779590
    [Abstract] [Full Text] [Related]

  • 3. Circulating classical CD14++CD16- monocytes predict shorter time to initial treatment in chronic lymphocytic leukemia patients: Differential effects of immune chemotherapy on monocyte-related membrane and soluble forms of CD163.
    Lapuc I, Bolkun L, Eljaszewicz A, Rusak M, Luksza E, Singh P, Miklasz P, Piszcz J, Ptaszynska-Kopczynska K, Jasiewicz M, Kaminski K, Dabrowska M, Bodzenta-Lukaszyk A, Kloczko J, Moniuszko M.
    Oncol Rep; 2015 Sep 28; 34(3):1269-78. PubMed ID: 26135617
    [Abstract] [Full Text] [Related]

  • 4. Expression of CD206 and CD163 on intermediate CD14++CD16+ monocytes are increased in hemorrhagic fever with renal syndrome and are correlated with disease severity.
    Li X, Du N, Xu G, Zhang P, Dang R, Jiang Y, Zhang K.
    Virus Res; 2018 Jul 15; 253():92-102. PubMed ID: 29857122
    [Abstract] [Full Text] [Related]

  • 5. Decreased classical monocytes and CD163 expression in TB patients: an indicator of drug resistance.
    Shahzad F, Bashir N, Ali A, Jabeen S, Kashif M, Javaid K, Tahir R, Abbas A, Jahan S, Afzal N.
    Braz J Microbiol; 2021 Jun 15; 52(2):607-617. PubMed ID: 33586094
    [Abstract] [Full Text] [Related]

  • 6. Human monocyte CD163 expression inversely correlates with soluble CD163 plasma levels.
    Davis BH, Zarev PV.
    Cytometry B Clin Cytom; 2005 Jan 15; 63(1):16-22. PubMed ID: 15624200
    [Abstract] [Full Text] [Related]

  • 7. Downregulation of CD163 in monocytes and its soluble form in the plasma is associated with a pro-inflammatory profile in pregnant women with preeclampsia.
    Nunes PR, Romão-Veiga M, Peraçoli JC, Araujo Costa RA, de Oliveira LG, Borges VTM, Peraçoli MT.
    Immunol Res; 2019 Jun 15; 67(2-3):194-201. PubMed ID: 31240481
    [Abstract] [Full Text] [Related]

  • 8. Altered monocyte phenotype and dysregulated innate cytokine responses among people living with HIV and opioid-use disorder.
    Underwood ML, Nguyen T, Uebelhoer LS, Kunkel LE, Korthuis PT, Lancioni CL.
    AIDS; 2020 Feb 01; 34(2):177-188. PubMed ID: 31687981
    [Abstract] [Full Text] [Related]

  • 9. The expansion of CD14+ CD163+ subpopulation of monocytes and myeloid cells-associated cytokine imbalance; candidate diagnostic biomarkers for celiac disease (CD).
    Babania O, Mohammadi S, Yaghoubi E, Sohrabi A, Sadat Seyedhosseini F, Abdolahi N, Yazdani Y.
    J Clin Lab Anal; 2021 Oct 01; 35(10):e23984. PubMed ID: 34449925
    [Abstract] [Full Text] [Related]

  • 10. Different phenotypes of monocytes in patients with new-onset mild acute pancreatitis.
    Zhang ML, Jiang YF, Wang XR, Ding LL, Wang HJ, Meng QQ, Gao PJ.
    World J Gastroenterol; 2017 Feb 28; 23(8):1477-1488. PubMed ID: 28293095
    [Abstract] [Full Text] [Related]

  • 11. Soluble CD163, a specific macrophage activation marker, is decreased by anti-TNF-α antibody treatment in active inflammatory bowel disease.
    Dige A, Støy S, Thomsen KL, Hvas CL, Agnholt J, Dahlerup JF, Møller HJ, Grønbaek H.
    Scand J Immunol; 2014 Dec 28; 80(6):417-23. PubMed ID: 25346048
    [Abstract] [Full Text] [Related]

  • 12. Differential expression of CD163 on monocyte subsets in healthy and HIV-1 infected individuals.
    Tippett E, Cheng WJ, Westhorpe C, Cameron PU, Brew BJ, Lewin SR, Jaworowski A, Crowe SM.
    PLoS One; 2011 Dec 28; 6(5):e19968. PubMed ID: 21625498
    [Abstract] [Full Text] [Related]

  • 13. Hemoglobin induces monocyte recruitment and CD163-macrophage polarization in abdominal aortic aneurysm.
    Rubio-Navarro A, Amaro Villalobos JM, Lindholt JS, Buendía I, Egido J, Blanco-Colio LM, Samaniego R, Meilhac O, Michel JB, Martín-Ventura JL, Moreno JA.
    Int J Cardiol; 2015 Dec 15; 201():66-78. PubMed ID: 26296046
    [Abstract] [Full Text] [Related]

  • 14. Elevated plasma soluble CD14 and skewed CD16+ monocyte distribution persist despite normalisation of soluble CD163 and CXCL10 by effective HIV therapy: a changing paradigm for routine HIV laboratory monitoring?
    Castley A, Berry C, French M, Fernandez S, Krueger R, Nolan D.
    PLoS One; 2014 Dec 15; 9(12):e115226. PubMed ID: 25544986
    [Abstract] [Full Text] [Related]

  • 15. Phenotypic commitment of monocytes towards a protective hemoglobin scavenging phenotype (CD14(pos)CD163(high)HLA-DR(low))following cardiopulmonary bypass.
    Quimby KR, Greenidge A, Harris A, Landis RC.
    Cytometry B Clin Cytom; 2010 Sep 15; 78(5):357-60. PubMed ID: 20533393
    [Abstract] [Full Text] [Related]

  • 16. Utility of Macrophage-activated Marker CD163 for Diagnosis and Prognosis in Pulmonary Tuberculosis.
    Suzuki Y, Shirai M, Asada K, Miwa S, Karayama M, Nakamura Y, Inui N, Shirai T, Hayakawa H, Baba S, Suda T.
    Ann Am Thorac Soc; 2017 Jan 15; 14(1):57-64. PubMed ID: 27684274
    [Abstract] [Full Text] [Related]

  • 17. CD163 as a Potential Biomarker of Monocyte Activation in Ischemic Stroke Patients.
    Greco R, Demartini C, Zanaboni AM, Tumelero E, Persico A, Candeloro E, Morotti A, Amantea D, Tassorelli C.
    Int J Mol Sci; 2021 Jun 23; 22(13):. PubMed ID: 34201498
    [Abstract] [Full Text] [Related]

  • 18. Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy.
    Burdo TH, Lentz MR, Autissier P, Krishnan A, Halpern E, Letendre S, Rosenberg ES, Ellis RJ, Williams KC.
    J Infect Dis; 2011 Jul 01; 204(1):154-63. PubMed ID: 21628670
    [Abstract] [Full Text] [Related]

  • 19. Expression of CD163 and HLA-DR molecules on the monocytes in chronic lymphocytic leukemia patients.
    Kowalska W.
    Folia Histochem Cytobiol; 2020 Jul 01; 58(1):17-24. PubMed ID: 32176313
    [Abstract] [Full Text] [Related]

  • 20. Monocyte CD163 is altered in association with diabetic complications: possible protective role.
    Min D, Brooks B, Wong J, Aamidor S, Seehoo R, Sutanto S, Harrisberg B, Yue DK, Twigg SM, McLennan SV.
    J Leukoc Biol; 2016 Dec 01; 100(6):1375-1383. PubMed ID: 27354410
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.